Local institution
Odense 5000
0 studies enrolling now · 13 studies all time
What they study most
Alzheimer's Disease, Atrial Fibrillation, Atrial Flutter, Brain Cancer, Chronic Genotype 1 Hepatitis C Virus Infection, Hepatitis C, Hepatitis C Virus, Lung Cancer - Non Small Cell Squamous, Melanoma, Multiple Myeloma, Pulmonary Embolism, Venous Thrombosis
Studies at this site
- An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) — Completed
- An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma — Completed
- Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin — Completed
- Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial — Completed
- Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab — Completed
- Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
- Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection — Completed
- Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness — Completed
- Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients — Completed
- Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment — Completed
- A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease — Completed
- Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials) — Completed
- A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1 — Completed